Viewing Study NCT03245151

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-01-04 @ 7:18 PM
Study NCT ID: NCT03245151
Status: COMPLETED
Last Update Posted: 2023-08-30
First Post: 2017-08-03
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
Sponsor: Eisai Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent and Refractory Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pediatrics View
None central nervous system tumors View
None lenvatinib View
None E7080 View
None everolimus View
None Ewing sarcoma/peripheral primitive neuroectodermal tumor View
None rhabdomyosarcoma View
None high grade glioma View
None solid tumors View